Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Hypertension Research
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. hypertension research
  3. original article
  4. article
Synthetic/Secreting and Apoptotic Phenotypes in Renal Biopsy Tissues from Hypertensive Nephrosclerosis Patients
Download PDF
Download PDF
  • Original Article
  • Published: 01 August 2006

Synthetic/Secreting and Apoptotic Phenotypes in Renal Biopsy Tissues from Hypertensive Nephrosclerosis Patients

  • Noriyo Kimura1,
  • Satomi Yonemoto2,
  • Toshihiko Machiguchi1,
  • Xuan Li1,
  • Hideki Kimura1 &
  • …
  • Haruyoshi Yoshida1 

Hypertension Research volume 29, pages 573–580 (2006)Cite this article

  • 899 Accesses

  • Metrics details

Abstract

The major glomerular abnormalities in hypertensive nephrosclerosis are described as glomerular obsolescence (GO), glomerulosclerosis (GS), and glomerular collapse (GC). However, glomerular cellular changes caused by hypertensive insults have not been well analyzed. Using an immunoenzyme method, we examined eleven biopsy samples from patients with hypertensive nephrosclerosis for two synthetic and secreting phenotypes, α-smooth muscle actin (α-SMA) and collagen type III (Col. III), and two apoptotic phenotypes, pro-apoptotic molecule Bax and anti-apoptotic molecule Bcl-2. Together with the glomerular and vascular changes and interstitial fibrosis (IF) area, the results were scored quantitatively and semi-quantitatively and compared to the clinical findings, which included systolic blood pressure (SBP), mean arterial pressure (MAP), serum creatinine levels (sCr) and creatinine clearance (Ccr), using univariate and multivariate analyses. As a result, GS was frequently observed in the mild-to-moderate hypertensive group (140≤SBP<180 mmHg), whereas GC was positively correlated with SBP. Furthermore, there was a positive correlation of GS with mesangial α-SMA and Col. III, suggesting that GS was the reflection of these synthetic and secreting phenotypic changes in mesangial cells. Endothelial Bax was positively correlated with Ccr (p<0.01); in contrast, podocytic Bax was positively correlated with sCr (p<0.05) and showed a tendency to correlate with MAP (p=0.054). In conclusion, these findings support the view that mesangial synthetic and secreting phenotypic changes may be a reflection of cellular activation caused by mild-to-moderate hypertension and that apoptotic phenotypic expression in podocytes, rather than endothelial cells, may be related to the development of a severe form of hypertensive nephrosclerosis.

Similar content being viewed by others

A new index for the outcome of focal segmental glomerulosclerosis

Article Open access 09 April 2024

Glomerular proteomic profiling of kidney biopsies with hypertensive nephropathy reveals a signature of disease progression

Article 14 October 2022

Machine learning for morbid glomerular hypertrophy

Article Open access 09 November 2022

Article PDF

References

  1. Helmcben U, Wenzel UO : Benign and malignant nephrosclerosis and renovascular disease, in Tisher CC, Brenner BM : Renal Pathology. Philadelphia, Lippincott, 1994, pp 1201–1236.

    Google Scholar 

  2. Olson JL : Hypertension: essential and secondary forms, in Jennette JC, Olson JL, Schwartz MM, Silva FG : Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, Lippincott, 1998, pp 943–1001.

    Google Scholar 

  3. Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303–312.

    Article  CAS  Google Scholar 

  4. Luft FC : Hypertensive nephrosclerosis: update. Curr Opin Nephrol Hypertens 2004; 13: 147–154.

    Article  Google Scholar 

  5. Inada H, Ono H, Minami J, Ishimitsu T, Matsuoka H : Nipradilol prevents L-NAME–exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR. Hypertens Res 2002; 25: 433–440.

    Article  CAS  Google Scholar 

  6. Rupprecht HD, Schocklmann HO, Sterzel RB : Glomerular mesangial cells, in Neilson EG, Couser WG : Immunologic Renal Disease, 2nd ed. Philadelphia, Lippincott, 2001, pp 657–691.

    Google Scholar 

  7. Sanders PW, Wang PX : Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats. BMC Nephrol 2002; 3: 1.

    Article  Google Scholar 

  8. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z : Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103–111.

    Article  CAS  Google Scholar 

  9. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED : Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300–1306.

    Article  CAS  Google Scholar 

  10. Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H : Imidapril improves L-NAME–exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats. J Hypertens 2004; 22: 1389–1395.

    Article  CAS  Google Scholar 

  11. Ying WZ, Wang PX, Sanders PW : Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int 2000; 58: 2007–2017.

    CAS  PubMed  Google Scholar 

  12. Ying WZ, Sanders PW : Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats. Kidney Int 2001; 59: 662–672.

    Article  CAS  Google Scholar 

  13. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure : The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.

  14. Fogo A, Breyer JA, Smith MC, et al, AASK Pilot Study Investigators : Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997; 51: 244–252.

    Article  CAS  Google Scholar 

  15. Takebayashi S, Kiyoshi Y, Hisano S, et al: Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol 2001; 55: 349–356.

    CAS  PubMed  Google Scholar 

  16. Kritz W, Kobayashi N, Elger M : New aspects of podocyte structure, function, and pathology. Clin Exp Nephrol 1998; 2: 85–99.

    Article  Google Scholar 

  17. Kretzler M, Koeppen-Hagemann I, Kriz W : Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch 1994; 425: 181–193.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Fukui Hospital, Fukui, Japan

    Noriyo Kimura, Toshihiko Machiguchi, Xuan Li, Hideki Kimura & Haruyoshi Yoshida

  2. Division of Nephrology, Medical Research Institute Kitano Hospital, Osaka, Japan

    Satomi Yonemoto

Authors
  1. Noriyo Kimura
    View author publications

    Search author on:PubMed Google Scholar

  2. Satomi Yonemoto
    View author publications

    Search author on:PubMed Google Scholar

  3. Toshihiko Machiguchi
    View author publications

    Search author on:PubMed Google Scholar

  4. Xuan Li
    View author publications

    Search author on:PubMed Google Scholar

  5. Hideki Kimura
    View author publications

    Search author on:PubMed Google Scholar

  6. Haruyoshi Yoshida
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Haruyoshi Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimura, N., Yonemoto, S., Machiguchi, T. et al. Synthetic/Secreting and Apoptotic Phenotypes in Renal Biopsy Tissues from Hypertensive Nephrosclerosis Patients. Hypertens Res 29, 573–580 (2006). https://doi.org/10.1291/hypres.29.573

Download citation

  • Received: 13 December 2005

  • Accepted: 18 April 2006

  • Issue date: 01 August 2006

  • DOI: https://doi.org/10.1291/hypres.29.573

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • α-smooth muscle actin
  • collagen type III
  • Bax
  • Bcl-2
Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open Access Fees and Funding
  • Guide to Authors
  • About the Editors
  • Message from Editors
  • Call for Paper
  • Contact
  • About the Partner
  • For Advertisers
  • Subscribe
  • Showcase of Graphical Abstracts on Hypertension Research

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Hypertension Research (Hypertens Res)

ISSN 1348-4214 (online)

ISSN 0916-9636 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited